Business Description
Shanghai Xiao Fang Pharmaceutical Co Ltd
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 392.83 | |||||
Equity-to-Asset | 0.83 | |||||
Interest Coverage | 6327.68 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 21.37 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.56 | |||||
9-Day RSI | 50.79 | |||||
14-Day RSI | 46.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.69 | |||||
Quick Ratio | 3.4 | |||||
Cash Ratio | 2.43 | |||||
Days Sales Outstanding | 11498.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 9822.24 | |||||
Operating Margin % | 7332.42 | |||||
Net Margin % | 6403.88 | |||||
FCF Margin % | 4439.05 | |||||
ROE % | 34.61 | |||||
ROA % | 28.62 | |||||
ROIC % | 48.68 | |||||
ROC (Joel Greenblatt) % | 83.09 | |||||
ROCE % | 38.21 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.64 | |||||
PE Ratio without NRI | 15.65 | |||||
Price-to-Owner-Earnings | 20.09 | |||||
PS Ratio | 1041.51 | |||||
PB Ratio | 6.12 | |||||
Price-to-Tangible-Book | 6.35 | |||||
Price-to-Free-Cash-Flow | 22.89 | |||||
Price-to-Operating-Cash-Flow | 14.17 | |||||
EV-to-EBIT | 16.24 | |||||
EV-to-EBITDA | 16.04 | |||||
EV-to-Revenue | 1210.23 | |||||
EV-to-FCF | 27.33 | |||||
Price-to-Graham-Number | 2.1 | |||||
Price-to-Net-Current-Asset-Value | 11.19 | |||||
Price-to-Net-Cash | 21.06 | |||||
Earnings Yield (Greenblatt) % | 6.16 | |||||
FCF Yield % | 3.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanghai Xiao Fang Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 3.193 | ||
EPS (TTM) (Â¥) | 1.71 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 46.33 | ||
14-Day ATR (Â¥) | 2.080345 | ||
20-Day SMA (Â¥) | 24.274 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (Â¥) | 20.5 - 39.5 | ||
Shares Outstanding (Mil) | 160 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Xiao Fang Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Xiao Fang Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shanghai Xiao Fang Pharmaceutical Co Ltd Frequently Asked Questions
What is Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207)'s stock price today?
When is next earnings date of Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207)?
Does Shanghai Xiao Fang Pharmaceutical Co Ltd(SHSE:603207) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |